Hap Trading, LLC Alaunos Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	BUY	$0.41 - $1.24 $41 - $124	100 Added 0.81%	12,400 $3,000
Q3 2021 Nov 10, 2021	BUY	$1.44 - $2.73 $17,712 - $33,579	12,300 New	12,300 $9,000
Q3 2019 Nov 12, 2019	SELL	$4.13 - $6.94 $59,059 - $99,242	-14,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $56,914 - $88,660	14,300 New	14,300 $8,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.